Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith T Flaherty

Showing results (171-180 of 418) with videos related to

Pageof 42
Sort By:
Cancer Discovery|September 27, 2014
The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFαMichael P Smith, Berta Sanchez-Laorden, Kate O'Brien, et al.
Cancer Research|June 17, 2010
Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte functionAndrea Boni, Alexandria P Cogdill, Ping Dang, et al.
Cancer Cell|December 9, 2008
HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinomaJohn D Gordan, Priti Lal, Vijay R Dondeti, et al.
Clinical Epigenetics|June 9, 2015
MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxel-based therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603Liza C Villaruz, Grace Huang, Marjorie Romkes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2017
BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant MelanomaHeike Niessner, Tobias Sinnberg, Corinna Kosnopfel, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2017
Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2015
Survival of patients with advanced metastatic melanoma: The impact of novel therapiesSelma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2017
Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug CombinationsAdam A Friedman, Yun Xia, Lorenzo Trippa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Large-scale analysis of KIT aberrations in Chinese patients with melanomaYan Kong, Lu Si, Yanyan Zhu, et al.
Oncotarget|April 16, 2014
PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutationFrancesco Sabbatino, Yangyang Wang, Xinhui Wang, et al.
Pageof 42

Showing results (171-180 of 418) with videos related to

Sort By:
Pageof 42
Cancer Discovery|September 27, 2014
The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFαMichael P Smith, Berta Sanchez-Laorden, Kate O'Brien, et al.
Cancer Research|June 17, 2010
Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte functionAndrea Boni, Alexandria P Cogdill, Ping Dang, et al.
Cancer Cell|December 9, 2008
HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinomaJohn D Gordan, Priti Lal, Vijay R Dondeti, et al.
Clinical Epigenetics|June 9, 2015
MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxel-based therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603Liza C Villaruz, Grace Huang, Marjorie Romkes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2017
BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant MelanomaHeike Niessner, Tobias Sinnberg, Corinna Kosnopfel, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2017
Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2015
Survival of patients with advanced metastatic melanoma: The impact of novel therapiesSelma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2017
Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug CombinationsAdam A Friedman, Yun Xia, Lorenzo Trippa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Large-scale analysis of KIT aberrations in Chinese patients with melanomaYan Kong, Lu Si, Yanyan Zhu, et al.
Oncotarget|April 16, 2014
PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutationFrancesco Sabbatino, Yangyang Wang, Xinhui Wang, et al.
Pageof 42